This inventor holds 7 USPTO granted patents. Top assignee: Jagotec Ag. Active years: 2003-2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003-2006
Title: Innovator Spotlight: Nils Ove Gustavsson
Introduction
Nils Ove Gustavsson, an esteemed inventor based in Löddeköpinge, Sweden, has made significant contributions to the field of biopharmaceuticals. With seven patents to his name, he is pioneering advancements in the production of purified starches and microparticles for parenteral administration. His research has not only expanded the practical applications of starch but also enhanced the solubility and efficacy of biologically active substances.
Latest Patents
Gustavsson's latest innovations include a method for the production of pharmaceutically acceptable starch. This process involves washing starch containing over 85% amylopectin to eliminate surface-localized proteins, lipids, and endotoxins, followed by dissolving the starch in an aqueous medium and reducing its molecular weight through shearing. Additionally, he has developed microparticles by combining purified amylopectin-based starch with biologically active substances to form an emulsion, which is subsequently gelled and dried. These microparticles are characterized by their low amino acid content and absence of covalent chemical cross-linking, making them particularly valuable in pharmaceutical applications.
Career Highlights
Nils Ove Gustavsson has dedicated a significant portion of his career to researching and developing innovative methods for starch processing. His work at Jagotec AG has positioned him as a leader in his field, focusing on creating products that improve drug delivery systems. His dedication to innovation has earned him recognition among peers and in the industry.
Collaborations
Throughout his career, Gustavsson has collaborated with talented coworkers such as Timo Laakso and Mats Reslow. Together, they have worked to refine and enhance the applications of starch in biopharmaceuticals, contributing to the development of cutting-edge technologies that bring forth new possibilities in medical treatment.
Conclusion
Nils Ove Gustavsson's inventive spirit and dedication to research continue to drive advancements in pharmaceuticals. His patented processes are paving the way for safer and more effective drug delivery methods, embodying the essence of innovation and impacting the medical field positively. With each new patent, he reaffirms his commitment to improving healthcare through science and technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile